{
  "ticker": "PNV",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968935",
  "id": "02968935",
  "pages": 1,
  "price_sensitive": false,
  "date": "20250714",
  "time": "0924",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrwgw8fw4lj9.pdf",
  "summary": "**Summary of ASX Announcement:**  \n\n- **Event:** Special briefing hosted by Bell Potter featuring Professor Toby Coates on PolyNovo's NovoSorb used in a **successful Type 1 diabetes islet cell transplant** (new market application).  \n- **Key Takeaway:** Demonstrates **expansion potential** of NovoSorb as a platform technology.  \n- **No material financial/trading impacts** disclosed (no capital, clinical trial results, or commercial agreements announced).  \n\n**Format:** Informational update; no actionable capital markets data.  \n\n*Omitted:* Webcast details, background info on PolyNovo/NovoSorb (non-material).",
  "usage": {
    "prompt_tokens": 673,
    "completion_tokens": 136,
    "total_tokens": 809,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-13T23:46:40.341811"
}